MENU
+Compare
BCAB
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.38
Change
-$0.00 (-0.00%)
Capitalization
22.43M

BCAB BioAtla Forecast, Technical & Fundamental Analysis

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BCAB with price predictions
Jun 27, 2025

BCAB's Stochastic Oscillator is sitting in oversold zone for 9 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BCAB advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BCAB moved out of overbought territory on June 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BCAB as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BCAB turned negative on June 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

BCAB moved below its 50-day moving average on June 13, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BCAB crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BCAB broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BCAB entered a downward trend on June 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BCAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (40.984) is normal, around the industry mean (16.377). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). BCAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.784) is also within normal values, averaging (252.527).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BCAB is expected to report earnings to rise 1.27% to -26 cents per share on August 07

BioAtla BCAB Stock Earnings Reports
Q2'25
Est.
$-0.26
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.19
Q2'24
Beat
by $0.01
The last earnings report on May 06 showed earnings per share of -25 cents, beating the estimate of -38 cents. With 389.59K shares outstanding, the current market capitalization sits at 22.43M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIF3.420.07
+2.09%
SIFCO Industries
ERII12.620.21
+1.69%
Energy Recovery
KDP32.850.04
+0.12%
Keurig Dr Pepper
BLKB64.07-0.18
-0.28%
Blackbaud
ASPI7.40-0.39
-5.01%
ASP Isotopes

BCAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with NVO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+2.37%
NVO - BCAB
39%
Loosely correlated
+1.20%
CRSP - BCAB
39%
Loosely correlated
N/A
OVID - BCAB
37%
Loosely correlated
-11.95%
CTMX - BCAB
37%
Loosely correlated
-2.60%
DNLI - BCAB
37%
Loosely correlated
-2.69%
More